Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

NCT02959463 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Pleural Malignant Mesothelioma

Interventions

OTHER: Laboratory Biomarker Analysis
RADIATION: Palliative Radiation Therapy
BIOLOGICAL: Pembrolizumab
RADIATION: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]